From MRA, November 17, 2021
Note: A link to the affected outlets can be found at the end of this article.
The Marijuana Regulatory Agency (MRA) has identified inaccurate and / or unreliable results of products tested by safety compliance facilities Viridis North, LLC and Viridis Laboratories, LLC.
In the interest of public health and safety, the MRA publishes this health and safety newsletter for all marijuana products tested by Viridis Laboratories, LLC (license numbers SC-000009 and AU -SC-000113) and Viridis North, LLC (license numbers SC-000014 and AU-SC-000103) with the exception of inhalable marijuana concentrate products such as:
- Vaping carts.
- Living resin.
- Any other cannabis concentrate created by extractions of residual solvents.
Affected marijuana products have a test date between August 10, 2021 and November 16, 2021. All marijuana product labels must show the name and license number of the safety compliance facility that performed the tests and the date the product was tested.
Note: An ARM investigation is still ongoing.
Consumers who have marijuana products in their possession that meet the recall criteria may return the products to the marijuana point of sale where they were purchased for proper disposal. Consumers with weakened immune systems or who suffer from lung diseases are at the highest risk for health-related incidents such as aspergillosis, which can impact lung function, if these potentially harmful products are consumed.
Consumers who have experienced adverse reactions after using these products should report their symptoms and use of the product to their doctor. Consumers are urged to report any adverse reactions to the product to the MRA by email: [email protected] or by phone: 517-284-8599.
Marijuana outlets that have sold product covered by this bulletin must display this recall notice on the sales floor, visible to all customers, for 30 days from the date of this PUBLIC HEALTH AND SAFETY BULLETIN 17 November 2021 This advisory bulletin does not constitute legal advice and is subject to change. Licensees are encouraged to consult with legal counsel to ensure their operations comply with the Marijuana for Medical Purposes Licensing Act and associated administrative rules. opinion. Marijuana outlets that receive adverse reactions to the product from consumers should report adverse reactions to the product to the agency at [email protected] and document these reports in METRC.
Licensees whose remaining products in their inventory meet the recall criteria have the following options:
- Destroy the product and provide proof of destruction: [email protected]
- Retest the product for the microbial compliance panel.
- Return the product to the original licensee’s source so that they can destroy or retest the product as a larger lot.
Licensees who choose to return or retest the product will need to create new METRC packages with new METRC identification numbers before transferring or submitting the products for testing. Additional guidance can be provided to licensees who need assistance creating these packages by contacting [email protected]
Additional questions can be sent to the MRA Operations Support section: [email protected]
Below is a link to the outlets affected by the recall.